Author correction to‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics’[Acta Pharm Sin B 12(2022)4458–4471]

作     者：Qiang Niu Yu Liu Yujing Zheng Ziwei Tang Yuna Qian Ruogu Qi Jianliang Shen Ping Zhao 

作者机构：School of Chemistry and Chemical EngineeringGuangdong Pharmaceutical UniversityGuangzhou 510006China State Key Laboratory of OphthalmologyOptometry and Vision ScienceSchool of Ophthalmology and OptometrySchool of Biomedical EngineeringWenzhou Medical UniversityWenzhou 325027China Wenzhou InstituteUniversity of Chinese Academy of SciencesWenzhou 325001China School of Medicine&Holistic Integrative MedicineNanjing University of Chinese MedicineNanjing 210023China 

出 版 物：《Acta Pharmaceutica Sinica B》 (药学学报（英文版）)

年 卷 期：2024年第14卷第5期

页      面：2359-2360页

核心收录：

学科分类：050302[文学-传播学] 05[文学] 1002[医学-临床医学] 100214[医学-肿瘤学] 0503[文学-新闻传播学] 10[医学] 

主　　题：journal correction conclusion 

摘      要：The authors regret that there is an error in Fig.6 in the article due to the mistake of copying and pasting in the process of assemblingfigures and negligence in the *** it does not affect the conclusion,it is an obvious *** authors have now modified as *** authors apologize for any inconvenience caused to the journal and readers.